John G. Compton
Director · 20/20 Biolabs, Inc.
Individual
- 2026
- Feb 23, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at John G. Compton's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Mark Hancock - $40.97M in PACS purchases and sales in the last 12 months
- EcoR1 Capital, LLC - $40.00M in AKTS purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $40.00M in BCAX purchases and sales in the last 12 months
- Sanj K. Patel - $39.43M in KNSA purchases and sales in the last 12 months
- Hellman & Friedman Capital Partners X (Parallel), L.P. - $2.65B in MDLN purchases and sales in the last 12 months
- BX Mozart ML-2 Holdco L.P. - $2.35B in MDLN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is John G. Compton?
John G. Compton is a corporate insider, tracked as Director of 20/20 Biolabs, Inc. (AIDX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did John G. Compton last file a Form 4?
The only primary Form 4 on record is dated 23 February 2026.
